BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9861928)

  • 1. PHARMAC and statins.
    Bennett W; McNee W
    N Z Med J; 1998 Nov; 111(1077):439-40. PubMed ID: 9861928
    [No Abstract]   [Full Text] [Related]  

  • 2. [SBU should investigate what is an evidence-based and cost-effective use of statins].
    Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1992-4. PubMed ID: 19764381
    [No Abstract]   [Full Text] [Related]  

  • 3. [New lower cholesterol levels: How much does it cost? Who is to pay?].
    Lindberg M
    Ugeskr Laeger; 2004 Nov; 166(49):4493-4; author reply 4494. PubMed ID: 15626108
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost benefit of pharmacy audit and nonrestrictive antibiotic policy.
    Ware GJ; Ford DJ
    N Z Med J; 1993 Apr; 106(954):160. PubMed ID: 8479665
    [No Abstract]   [Full Text] [Related]  

  • 5. PHARMAC at what cost?
    Moodie P; McNee W
    N Z Med J; 2000 Feb; 113(1104):64. PubMed ID: 10777230
    [No Abstract]   [Full Text] [Related]  

  • 6. [Statins and costs of prevented death cases].
    Robberstad T
    Tidsskr Nor Laegeforen; 1997 Nov; 117(28):4131. PubMed ID: 9441454
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contribution to statins?].
    Heebøll-Nielsen NC; Ahnfeldt-Mollerup I
    Ugeskr Laeger; 1998 Sep; 160(37):5376-7. PubMed ID: 9748871
    [No Abstract]   [Full Text] [Related]  

  • 8. [Simvastatin 40 mg as secondary prophylaxis: Effective, tolerable and cost-efficient!].
    Hernborg A; Hjemdahl P; Håkansson J
    Lakartidningen; 2006 Mar 15-21; 103(11):858, 861; discussion 861-2. PubMed ID: 16613120
    [No Abstract]   [Full Text] [Related]  

  • 9. [When cholesterol lowering drugs should not be too expensive. Statins are especially effective in secondary prevention].
    Thomas HP; Kassner U; Steinhagen-Thiessen E
    MMW Fortschr Med; 2000 Jul; 142(30):33-4. PubMed ID: 10955017
    [No Abstract]   [Full Text] [Related]  

  • 10. [New lower cholesterol levels--more debate].
    Lindberg M
    Ugeskr Laeger; 2005 Jan; 167(3):307-8; author reply 308-9. PubMed ID: 15704805
    [No Abstract]   [Full Text] [Related]  

  • 11. RE: M Thomas. The change of cost: reference-based pricing and the statins. 1999;15:535-8.
    McNee W
    Can J Cardiol; 1999 Nov; 15(11):1287. PubMed ID: 10841625
    [No Abstract]   [Full Text] [Related]  

  • 12. [Consequences of cholesterol reduction in cardiovascular diseases. What costs should be allowed to prolong life a year?].
    De Faire U
    Lakartidningen; 1997 Dec; 94(49):4607-9. PubMed ID: 9445932
    [No Abstract]   [Full Text] [Related]  

  • 13. [Be careful about pseudo-information on cost-effectiveness].
    Lindberg M
    Lakartidningen; 1998 Jan; 95(3):144. PubMed ID: 9467283
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contribution to anticholesteremic agents?].
    Astrup P; Gyntelberg F
    Ugeskr Laeger; 1998 Jun; 160(24):3574-6. PubMed ID: 9641049
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heart failure is expensive! Correct drug utilization can reduce the number of of expensive days in hospital].
    Andersson F; Rydén-Bergsten T
    Lakartidningen; 1998 Jun; 95(24):2828-30. PubMed ID: 9656639
    [No Abstract]   [Full Text] [Related]  

  • 16. [Isn't it good if one person out of 600 treated with statins will get better?].
    Molander N
    Lakartidningen; 2004 Jul; 101(28-29):2365. PubMed ID: 15291322
    [No Abstract]   [Full Text] [Related]  

  • 17. [Summary of the 'Cholesterol' guideline (first revision) of the Dutch College of Family Practice].
    Bonneux L
    Ned Tijdschr Geneeskd; 2000 Apr; 144(18):862-3. PubMed ID: 10816777
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of splitting simvastatin tablets for control of low-density lipoprotein cholesterol.
    Parra D; Beckey NP; Raval HS; Schnacky KR; Calabrese V; Coakley RW; Goodhope RC;
    Am J Cardiol; 2005 Jun; 95(12):1481-3. PubMed ID: 15950578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New cholesterol drugs are overpriced, independent analysis finds.
    McCarthy M
    BMJ; 2015 Sep; 351():h4864. PubMed ID: 26359445
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical focus on statins.
    Auer J; Eber B
    Curr Opin Investig Drugs; 2001 Mar; 2(3):382-8. PubMed ID: 11575709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.